Antimalarial [EPC]

Antimalarial [EPC] was reported 10476 times

Drugs of the Antimalarial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA 13 0.2549
1 PARASITE BLOOD TEST POSITIVE 8 0.2353
2 MALARIA 138 0.1957
3 IVTH NERVE PARALYSIS 42 0.1772
4 PLASMODIUM FALCIPARUM INFECTION 21 0.1694
5 PHALANGEAL HYPOPLASIA 12 0.1690
6 CONGENITAL ABSENCE OF CRANIAL VAULT 8 0.1379
7 ENCEPHALITIS PROTOZOAL 7 0.1250
8 HAEMOPHILUS BACTERAEMIA 6 0.1224
9 CUTANEOUS MUCORMYCOSIS 21 0.1141
10 ACANTHAMOEBA INFECTION 17 0.0904
11 HEPATIC AMOEBIASIS 6 0.0896
12 CAMPYLOBACTER TEST POSITIVE 6 0.0789
13 CUTANEOUS NOCARDIOSIS 9 0.0692
14 TOTAL LUNG CAPACITY INCREASED 17 0.0625
15 MALACOPLAKIA 28 0.0611
16 DISSEMINATED TOXOPLASMOSIS 7 0.0583
17 PULMONARY NOCARDIOSIS 47 0.0570
18 SPONTANEOUS BACTERIAL PERITONITIS 12 0.0492
19 SCROTAL ULCER 11 0.0421
20 SUSPECTED DRUG-INDUCED LIVER INJURY 8 0.0400
21 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 10 0.0368
22 NOCARDIOSIS 94 0.0367
23 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 8 0.0362
24 CEREBELLAR STROKE 14 0.0358
25 CHEST WALL ABSCESS 7 0.0354
26 MORGANELLA INFECTION 10 0.0341
27 PENILE ULCERATION 11 0.0336
28 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 17 0.0325
29 DEVICE RELATED BACTERAEMIA 10 0.0323
30 BURKHOLDERIA CEPACIA COMPLEX INFECTION 8 0.0280
31 IGA NEPHROPATHY 46 0.0277
32 LEISHMANIASIS 8 0.0276
33 CONGENITAL FOOT MALFORMATION 12 0.0264
34 CONGENITAL APLASIA 8 0.0257
35 ANAEMIA MEGALOBLASTIC 11 0.0247
36 XANTHOPSIA 8 0.0217
37 JARISCH-HERXHEIMER REACTION 15 0.0211
38 PNEUMOCYSTIS JIROVECII INFECTION 25 0.0209
39 TOXOPLASMOSIS 22 0.0204
40 CEREBRAL TOXOPLASMOSIS 18 0.0193
41 ENTEROCOCCAL BACTERAEMIA 20 0.0189
42 PROTEUS INFECTION 13 0.0181
43 HUMAN HERPESVIRUS 8 INFECTION 11 0.0181
44 DISSEMINATED MUCORMYCOSIS 7 0.0178
45 ARTERIOVENOUS FISTULA THROMBOSIS 6 0.0173
46 FUSARIUM INFECTION 12 0.0171
47 WOUND INFECTION BACTERIAL 7 0.0169
48 CHYLOTHORAX 12 0.0166
49 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0165
50 PNEUMOCYSTIS JIROVECII PNEUMONIA 155 0.0154
51 VASOGENIC CEREBRAL OEDEMA 11 0.0153
52 LUNG TRANSPLANT REJECTION 10 0.0152
53 VULVAL DISORDER 10 0.0151
54 GRAFT VERSUS HOST DISEASE IN LUNG 7 0.0146
55 VANISHING BILE DUCT SYNDROME 16 0.0143
56 EVANS SYNDROME 7 0.0142
57 SYPHILIS 10 0.0138
58 MIXED LIVER INJURY 41 0.0136
59 DISSEMINATED CRYPTOCOCCOSIS 10 0.0132
60 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 12 0.0130
61 NEURAL TUBE DEFECT 9 0.0124
62 ANAL ULCER 10 0.0122
63 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 61 0.0122
64 MARROW HYPERPLASIA 8 0.0117
65 IMMUNE RECONSTITUTION SYNDROME 15 0.0116
66 ACQUIRED IMMUNODEFICIENCY SYNDROME 6 0.0116
67 MUCORMYCOSIS 30 0.0115
68 DELAYED GRAFT FUNCTION 8 0.0113
69 MYCOBACTERIAL INFECTION 19 0.0110
70 GRAFT VERSUS HOST DISEASE 79 0.0110
71 ENTEROCOCCAL INFECTION 53 0.0110
72 METHAEMOGLOBINAEMIA 24 0.0104
73 GENE MUTATION 20 0.0101
74 CYTOMEGALOVIRUS TEST POSITIVE 18 0.0101
75 SYSTEMIC CANDIDA 25 0.0099
76 ENTEROCOCCAL SEPSIS 8 0.0099
77 HYPOMANIA 34 0.0092
78 THROMBOTIC MICROANGIOPATHY 90 0.0092
79 INFECTIOUS PLEURAL EFFUSION 14 0.0092
80 LICHENOID KERATOSIS 21 0.0092
81 PNEUMONIA FUNGAL 36 0.0091
82 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 54 0.0091
83 STAPHYLOCOCCAL SKIN INFECTION 11 0.0089
84 ENTEROBACTER INFECTION 15 0.0089
85 CYTOMEGALOVIRUS CHORIORETINITIS 17 0.0087
86 HEPATIC CYTOLYSIS 111 0.0087
87 PARAINFLUENZAE VIRUS INFECTION 13 0.0085
88 KLEBSIELLA BACTERAEMIA 8 0.0084
89 VOCAL CORD PARALYSIS 15 0.0084
90 KLEBSIELLA INFECTION 41 0.0081
91 CYTOMEGALOVIRUS VIRAEMIA 34 0.0076
92 PNEUMOCYSTIS JIROVECI PNEUMONIA 17 0.0076
93 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0076
94 GASTROINTESTINAL INJURY 20 0.0074
95 STAPHYLOCOCCAL BACTERAEMIA 32 0.0074
96 GRAFT VERSUS HOST DISEASE IN SKIN 16 0.0073
97 VIRAEMIA 10 0.0072
98 LYME DISEASE 24 0.0072
99 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 53 0.0071
100 APHTHOUS STOMATITIS 16 0.0069
101 BONE MARROW TRANSPLANT 13 0.0068
102 HISTOPLASMOSIS 12 0.0068
103 ASPERGILLUS INFECTION 44 0.0067
104 GRANULOMATOSIS WITH POLYANGIITIS 8 0.0066
105 BICYTOPENIA 13 0.0066
106 FEBRILE BONE MARROW APLASIA 28 0.0066
107 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 14 0.0066
108 PNEUMONIA KLEBSIELLA 12 0.0065
109 JAUNDICE CHOLESTATIC 23 0.0065
110 OTOTOXICITY 12 0.0065
111 MYCOBACTERIUM AVIUM COMPLEX INFECTION 17 0.0063
112 ABORTION MISSED 8 0.0063
113 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 7 0.0062
114 CYTOKINE RELEASE SYNDROME 125 0.0062
115 PNEUMONIA CYTOMEGALOVIRAL 12 0.0062
116 RASH MORBILLIFORM 17 0.0061
117 ANAEMIA MACROCYTIC 13 0.0061
118 DEMYELINATING POLYNEUROPATHY 6 0.0058
119 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 19 0.0057
120 ORAL MUCOSA EROSION 7 0.0057
121 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 8 0.0057
122 PERSECUTORY DELUSION 14 0.0056
123 AGRANULOCYTOSIS 104 0.0056
124 ESCHERICHIA BACTERAEMIA 13 0.0055
125 PULMONARY SEPSIS 8 0.0055
126 CHOLESTATIC LIVER INJURY 12 0.0054
127 BLOOD PRESSURE SYSTOLIC ABNORMAL 13 0.0053
128 LUNG ABSCESS 11 0.0052
129 VASCULAR PSEUDOANEURYSM 9 0.0052
130 BRONCHOPULMONARY ASPERGILLOSIS 40 0.0052
131 BRAIN ABSCESS 13 0.0051
132 IMMUNE-MEDIATED HEPATIC DISORDER 10 0.0051
133 THROMBOCYTOPENIC PURPURA 7 0.0051
134 HISTOPLASMOSIS DISSEMINATED 8 0.0050
135 PNEUMOMEDIASTINUM 9 0.0050
136 LUNG OPACITY 13 0.0049
137 ORGANISING PNEUMONIA 24 0.0048
138 ADENOVIRUS INFECTION 14 0.0048
139 BACTERAEMIA 57 0.0048
140 CYTOPENIA 58 0.0047
141 LEUKAEMIA RECURRENT 8 0.0047
142 BLOOD AMYLASE INCREASED 8 0.0047
143 STEROID DIABETES 7 0.0047
144 TONGUE COATED 8 0.0046
145 MYOPIA 11 0.0046
146 TOXIC EPIDERMAL NECROLYSIS 70 0.0046
147 VARICELLA 11 0.0046
148 CYTOMEGALOVIRUS INFECTION REACTIVATION 20 0.0045
149 ENCEPHALOPATHY 110 0.0045
150 FUNGAEMIA 7 0.0044
151 ESCHERICHIA INFECTION 36 0.0044
152 CENTRAL NERVOUS SYSTEM LYMPHOMA 6 0.0044
153 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 12 0.0043
154 RHINITIS ALLERGIC 19 0.0043
155 OESOPHAGEAL CANDIDIASIS 17 0.0043
156 OPTIC NEUROPATHY 9 0.0042
157 ACUTE MYELOID LEUKAEMIA RECURRENT 9 0.0042
158 BRONCHIECTASIS 28 0.0042
159 HYPERURICAEMIA 17 0.0041
160 SLEEP TALKING 7 0.0041
161 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 32 0.0041
162 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
163 HYPERBILIRUBINAEMIA 42 0.0041
164 PANCYTOPENIA 225 0.0040
165 DIFFUSE LARGE B-CELL LYMPHOMA 31 0.0040
166 SPLENIC INFARCTION 7 0.0040
167 MENINGITIS CRYPTOCOCCAL 7 0.0040
168 FANCONI SYNDROME ACQUIRED 7 0.0040
169 SERUM FERRITIN INCREASED 21 0.0040
170 CYTOMEGALOVIRUS INFECTION 66 0.0040
171 LUNG TRANSPLANT 14 0.0040
172 IMMUNE-MEDIATED HEPATITIS 8 0.0039
173 CALCULUS URINARY 6 0.0039
174 RASH MACULO-PAPULAR 86 0.0039
175 B-CELL LYMPHOMA 13 0.0038
176 PNEUMONIA BACTERIAL 35 0.0038
177 RESPIRATORY SYNCYTIAL VIRUS INFECTION 33 0.0038
178 SARCOIDOSIS 18 0.0038
179 PULMONARY ALVEOLAR HAEMORRHAGE 21 0.0037
180 TOOTH DISCOLOURATION 11 0.0037
181 FEBRILE NEUTROPENIA 248 0.0037
182 CRYPTOCOCCOSIS 6 0.0037
183 EPSTEIN-BARR VIRUS INFECTION 23 0.0037
184 DRUG RESISTANCE 94 0.0037
185 NASAL POLYPS 18 0.0037
186 MOUTH ULCERATION 77 0.0037
187 CHOLESTASIS 70 0.0036
188 RHINOVIRUS INFECTION 14 0.0036
189 BRAIN DEATH 11 0.0036
190 KIDNEY TRANSPLANT REJECTION 17 0.0035
191 SCHIZOPHRENIA 43 0.0035
192 READING DISORDER 8 0.0035
193 TRANSPLANT REJECTION 28 0.0035
194 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
195 EXTREMITY NECROSIS 6 0.0034
196 PARTIAL SEIZURES 18 0.0034
197 BILIRUBIN CONJUGATED INCREASED 8 0.0034
198 PROTEIN TOTAL INCREASED 9 0.0034
199 ANGIONEUROTIC OEDEMA 9 0.0034
200 HAEMOLYSIS 26 0.0034
201 EYE CONTUSION 7 0.0033
202 COVID-19 PNEUMONIA 39 0.0033
203 CUTANEOUS VASCULITIS 12 0.0033
204 BK VIRUS INFECTION 11 0.0033
205 APLASTIC ANAEMIA 17 0.0033
206 HAEMOLYTIC ANAEMIA 29 0.0032
207 VENOOCCLUSIVE DISEASE 8 0.0032
208 CLOSTRIDIUM TEST POSITIVE 7 0.0032
209 BLOOD PRESSURE DIASTOLIC ABNORMAL 8 0.0031
210 DERMATITIS ACNEIFORM 19 0.0031
211 CLOSTRIDIUM DIFFICILE COLITIS 33 0.0031
212 COMPLICATIONS OF TRANSPLANTED KIDNEY 7 0.0031
213 FAILURE TO THRIVE 16 0.0031
214 ACUTE MYELOID LEUKAEMIA 48 0.0031
215 ABSCESS LIMB 13 0.0030
216 LIVER TRANSPLANT 11 0.0030
217 HAEMOLYTIC URAEMIC SYNDROME 7 0.0030
218 ACUTE RESPIRATORY FAILURE 58 0.0030
219 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 77 0.0030
220 HYPOGAMMAGLOBULINAEMIA 19 0.0029
221 DRUG ERUPTION 51 0.0029
222 ODYNOPHAGIA 17 0.0028
223 ACUTE GRAFT VERSUS HOST DISEASE 13 0.0028
224 RESPIRATORY FAILURE 207 0.0028
225 VENOOCCLUSIVE LIVER DISEASE 14 0.0028
226 HYPERVOLAEMIA 14 0.0028
227 SEPTIC SHOCK 121 0.0028
228 CHRONIC GRAFT VERSUS HOST DISEASE 10 0.0028
229 URINARY TRACT INFECTION BACTERIAL 7 0.0028
230 RALES 16 0.0028
231 PATHOGEN RESISTANCE 25 0.0027
232 INFECTION SUSCEPTIBILITY INCREASED 6 0.0027
233 ENDOMETRIAL CANCER 6 0.0027
234 THROMBOCYTOPENIA 305 0.0027
235 DUODENAL ULCER 19 0.0027
236 DRUG LEVEL INCREASED 44 0.0027
237 HIV INFECTION 8 0.0027
238 STEVENS-JOHNSON SYNDROME 59 0.0027
239 VASCULAR DEVICE INFECTION 12 0.0026
240 DISSEMINATED INTRAVASCULAR COAGULATION 37 0.0026
241 ANHEDONIA 69 0.0026
242 CYTOMEGALOVIRUS COLITIS 6 0.0026
243 HEPATOTOXICITY 58 0.0026
244 ECONOMIC PROBLEM 39 0.0026
245 OESOPHAGITIS 28 0.0026
246 BLOOD BILIRUBIN INCREASED 69 0.0026
247 PNEUMONIA VIRAL 8 0.0025
248 ACUTE RESPIRATORY DISTRESS SYNDROME 44 0.0025
249 MULTIPLE ORGAN DYSFUNCTION SYNDROME 70 0.0025
250 PLASMA CELL MYELOMA RECURRENT 8 0.0025
251 HERPES SIMPLEX 16 0.0025
252 DIARRHOEA HAEMORRHAGIC 23 0.0025
253 RETINAL VEIN OCCLUSION 7 0.0024
254 CANDIDA INFECTION 41 0.0024
255 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 6 0.0024
256 BLOOD IMMUNOGLOBULIN G DECREASED 6 0.0024
257 HEPATIC ENZYME ABNORMAL 12 0.0024
258 IMMUNOSUPPRESSION 21 0.0024
259 JAUNDICE 64 0.0024
260 TONGUE ULCERATION 8 0.0024
261 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
262 LUNG NEOPLASM 10 0.0023
263 ATYPICAL PNEUMONIA 7 0.0023
264 RASH PUSTULAR 17 0.0023
265 AUTOIMMUNE HAEMOLYTIC ANAEMIA 8 0.0023
266 SHOCK HAEMORRHAGIC 19 0.0023
267 LYMPHOPENIA 33 0.0023
268 PSEUDOMONAS INFECTION 20 0.0023
269 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 6 0.0023
270 PORTAL HYPERTENSION 7 0.0023
271 ERYTHEMA MULTIFORME 21 0.0022
272 TRANSAMINASES INCREASED 50 0.0022
273 MENINGITIS 15 0.0022
274 RENAL TUBULAR NECROSIS 22 0.0022
275 RENAL TRANSPLANT 8 0.0022
276 BONE MARROW FAILURE 45 0.0022
277 NEUTROPENIA 301 0.0022
278 DERMATITIS BULLOUS 16 0.0022
279 CARDIAC MURMUR 19 0.0022
280 OSTEOPENIA 33 0.0022
281 BLOOD PRESSURE DIASTOLIC INCREASED 10 0.0022
282 COLITIS 82 0.0022
283 LUNG INFILTRATION 19 0.0021
284 STOMACH DISCOMFORT 11 0.0021
285 GAMMA-GLUTAMYLTRANSFERASE INCREASED 47 0.0021
286 ESCHERICHIA URINARY TRACT INFECTION 9 0.0021
287 CHRONIC LYMPHOCYTIC LEUKAEMIA 10 0.0021
288 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
289 EOSINOPHILIA 36 0.0021
290 STAPHYLOCOCCAL SEPSIS 10 0.0020
291 ANOREXIA 26 0.0020
292 NEUTROPHIL COUNT DECREASED 82 0.0020
293 HEPATITIS ACUTE 13 0.0020
294 THROMBOTIC THROMBOCYTOPENIC PURPURA 7 0.0020
295 BONE MARROW DISORDER 6 0.0020
296 HEPATOCELLULAR INJURY 28 0.0020
297 END STAGE RENAL DISEASE 36 0.0020
298 HYPERTHERMIA 15 0.0020
299 DIASTOLIC DYSFUNCTION 6 0.0019
300 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 16 0.0019
301 RENAL FUNCTION TEST ABNORMAL 9 0.0019
302 LEUKOCYTOSIS 35 0.0019
303 APHTHOUS ULCER 15 0.0019
304 ACUTE KIDNEY INJURY 294 0.0019
305 AMYLASE INCREASED 7 0.0019
306 CARDIAC DYSFUNCTION 7 0.0019
307 HEPATIC NECROSIS 7 0.0019
308 GINGIVITIS 10 0.0019
309 HEPATIC FUNCTION ABNORMAL 69 0.0018
310 ABNORMAL DREAMS 51 0.0018
311 BACTERIAL SEPSIS 6 0.0018
312 LIPASE INCREASED 14 0.0018
313 HYPERKALAEMIA 64 0.0018
314 OESOPHAGEAL ULCER 7 0.0018
315 PLASMA CELL MYELOMA 71 0.0018
316 STAPHYLOCOCCAL INFECTION 60 0.0018
317 TUMOUR LYSIS SYNDROME 16 0.0018
318 HYPOXIA 64 0.0018
319 CYTOLYTIC HEPATITIS 6 0.0018
320 CHOLELITHIASIS 59 0.0018
321 NECROSIS 10 0.0018
322 TOXIC SKIN ERUPTION 18 0.0018
323 PYREXIA 618 0.0018
324 DRUG-INDUCED LIVER INJURY 56 0.0018
325 IRON DEFICIENCY 8 0.0018
326 CHOLANGITIS 11 0.0018
327 PLATELET COUNT DECREASED 189 0.0018
328 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
329 HYPOPHOSPHATAEMIA 13 0.0018
330 HYPERLIPIDAEMIA 21 0.0018
331 SKIN LESION 48 0.0017
332 SKIN PAPILLOMA 7 0.0017
333 APLASIA PURE RED CELL 6 0.0017
334 LEUKOPENIA 87 0.0017
335 CYSTITIS HAEMORRHAGIC 7 0.0017
336 SEPSIS 193 0.0017
337 NEPHROGENIC ANAEMIA 8 0.0017
338 ALANINE AMINOTRANSFERASE INCREASED 106 0.0017
339 AUTOIMMUNE HEPATITIS 12 0.0017
340 GASTRITIS EROSIVE 8 0.0017
341 ERYTHEMA NODOSUM 6 0.0017
342 PAPULE 12 0.0017
343 PHARYNGOLARYNGEAL PAIN 9 0.0017
344 FIBRIN D DIMER INCREASED 6 0.0017
345 CONJUNCTIVAL HYPERAEMIA 6 0.0017
346 VIRAL UPPER RESPIRATORY TRACT INFECTION 8 0.0017
347 RECALLED PRODUCT ADMINISTERED 16 0.0017
348 ANAL ABSCESS 9 0.0017
349 HEPATIC FAILURE 50 0.0017
350 ELECTROLYTE IMBALANCE 19 0.0016
351 PSYCHOTIC DISORDER 48 0.0016
352 ALTERED STATE OF CONSCIOUSNESS 35 0.0016
353 PROTEIN URINE PRESENT 8 0.0016
354 HYPOPHAGIA 41 0.0016
355 ABORTION INDUCED 15 0.0016
356 CHEMOTHERAPY 6 0.0016
357 HYPOCALCAEMIA 30 0.0016
358 ABDOMINAL ABSCESS 7 0.0016
359 DYSLIPIDAEMIA 8 0.0016
360 VENTRICULAR SEPTAL DEFECT 9 0.0016
361 BLOOD ALKALINE PHOSPHATASE INCREASED 39 0.0016
362 VISUAL DISTURBANCE 9 0.0016
363 BRAIN NEOPLASM MALIGNANT 7 0.0016
364 SHOCK 36 0.0016
365 ENTEROCOLITIS 9 0.0016
366 PULMONARY TOXICITY 11 0.0016
367 HAEMOGLOBIN ABNORMAL 10 0.0016
368 SUSPECTED OFF LABEL USE 7 0.0015
369 ASPARTATE AMINOTRANSFERASE INCREASED 82 0.0015
370 SPLENOMEGALY 18 0.0015
371 DISEASE COMPLICATION 7 0.0015
372 IMMUNE THROMBOCYTOPENIA 7 0.0015
373 LYMPHOCYTE COUNT DECREASED 27 0.0015
374 BLOOD LACTIC ACID INCREASED 8 0.0015
375 PANCREATITIS ACUTE 34 0.0015
376 PLEURAL EFFUSION 92 0.0015
377 GASTROENTERITIS 22 0.0015
378 RASH GENERALISED 39 0.0015
379 PNEUMONITIS 41 0.0015
380 BLOOD PRESSURE DIASTOLIC DECREASED 11 0.0015
381 INTERSTITIAL LUNG DISEASE 72 0.0015
382 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 14 0.0015
383 FAECALOMA 8 0.0015
384 MYELODYSPLASTIC SYNDROME 21 0.0015
385 PETECHIAE 15 0.0014
386 DRUG EXPOSURE DURING PREGNANCY 48 0.0014
387 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 77 0.0014
388 ISCHAEMIC STROKE 25 0.0014
389 BACTERIAL INFECTION 26 0.0014
390 FULL BLOOD COUNT DECREASED 28 0.0014
391 BLOOD PRESSURE SYSTOLIC INCREASED 27 0.0014
392 LEUKAEMIA 13 0.0014
393 DRUG LEVEL DECREASED 14 0.0014
394 RED BLOOD CELL COUNT DECREASED 39 0.0014
395 GINGIVAL SWELLING 6 0.0014
396 CEREBRAL DISORDER 10 0.0014
397 SKIN NECROSIS 7 0.0013
398 SKIN MASS 9 0.0013
399 QUALITY OF LIFE DECREASED 18 0.0013
400 PERICARDIAL EFFUSION 31 0.0013
401 RESPIRATORY DISTRESS 37 0.0013
402 HALLUCINATION 101 0.0013
403 NEPHROPATHY TOXIC 15 0.0013
404 DRUG INTERACTION 212 0.0013
405 HYDRONEPHROSIS 10 0.0013
406 HEPATIC ENZYME INCREASED 91 0.0013
407 HEPATITIS 34 0.0013
408 HEPATITIS CHOLESTATIC 8 0.0013
409 HEPATOMEGALY 13 0.0013
410 CHILLS 155 0.0013
411 LIVER DISORDER 58 0.0013
412 FACE OEDEMA 22 0.0013
413 CHEILITIS 7 0.0013
414 HYPOALBUMINAEMIA 10 0.0013
415 PNEUMONIA 411 0.0013
416 ANAEMIA 241 0.0013
417 LIVER INJURY 31 0.0013
418 ASCITES 37 0.0013
419 NEUROTOXICITY 22 0.0013
420 WHITE BLOOD CELL COUNT ABNORMAL 8 0.0013
421 PURPURA 11 0.0012
422 ATELECTASIS 12 0.0012
423 CHROMATURIA 28 0.0012
424 CLOSTRIDIUM DIFFICILE INFECTION 27 0.0012
425 RENAL FAILURE 164 0.0012
426 INCORRECT DOSAGE ADMINISTERED 6 0.0012
427 MYOSITIS 11 0.0012
428 NEUROLOGICAL SYMPTOM 7 0.0012
429 LUNG DISORDER 60 0.0012
430 DYSGRAPHIA 8 0.0012
431 SPINAL COMPRESSION FRACTURE 10 0.0012
432 SKIN REACTION 17 0.0012
433 METABOLIC DISORDER 7 0.0012
434 DECREASED ACTIVITY 13 0.0012
435 HYPERTRIGLYCERIDAEMIA 7 0.0012
436 DYSPNOEA EXERTIONAL 45 0.0012
437 GRAND MAL CONVULSION 11 0.0012
438 BLOOD CREATININE INCREASED 77 0.0012
439 RENAL IMPAIRMENT 99 0.0012
440 TACHYPNOEA 16 0.0012
441 ENDOCARDITIS 6 0.0012
442 ECCHYMOSIS 8 0.0012
443 MYOPATHY 10 0.0012
444 ENCEPHALITIS 8 0.0012
445 PYELONEPHRITIS 10 0.0012
446 ADRENAL INSUFFICIENCY 14 0.0012
447 CELLULITIS 58 0.0011
448 HYPOKALAEMIA 53 0.0011
449 IMMUNODEFICIENCY 17 0.0011
450 BLOOD ALBUMIN DECREASED 9 0.0011
451 WHITE BLOOD CELL COUNT DECREASED 122 0.0011
452 HYPERGLYCAEMIA 41 0.0011
453 COVID-19 196 0.0011
454 VASCULITIS 13 0.0011
455 FUNGAL INFECTION 37 0.0011
456 TREATMENT FAILURE 90 0.0011
457 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
458 BLOOD UREA INCREASED 18 0.0011
459 NEUTROPHIL COUNT INCREASED 11 0.0011
460 MALNUTRITION 12 0.0011
461 C-REACTIVE PROTEIN INCREASED 39 0.0011
462 MUCOSAL INFLAMMATION 28 0.0011
463 NIGHTMARE 37 0.0011
464 OXYGEN SATURATION DECREASED 60 0.0011
465 LIVER FUNCTION TEST ABNORMAL 31 0.0011
466 ORAL CANDIDIASIS 14 0.0011
467 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
468 STOMATITIS 64 0.0011
469 INTERNATIONAL NORMALISED RATIO INCREASED 30 0.0011
470 PARANOIA 18 0.0010
471 MATERNAL DRUGS AFFECTING FOETUS 8 0.0010
472 BLOOD MAGNESIUM DECREASED 9 0.0010
473 MULTI-ORGAN FAILURE 18 0.0010
474 DEVICE RELATED INFECTION 16 0.0010
475 RENAL FAILURE ACUTE 44 0.0010
476 LYMPHOMA 16 0.0010
477 HYPOVOLAEMIA 6 0.0010
478 MATERNAL EXPOSURE BEFORE PREGNANCY 7 0.0010
479 LIVER FUNCTION TEST INCREASED 22 0.0010
480 NIGHT SWEATS 33 0.0010
481 BONE DENSITY DECREASED 32 0.0010
482 CONDITION AGGRAVATED 308 0.0010
483 DISEASE RECURRENCE 48 0.0010
484 PNEUMOTHORAX 16 0.0010
485 PULMONARY MASS 15 0.0010
486 HYPERTRANSAMINASAEMIA 7 0.0010
487 PHARMACEUTICAL PRODUCT COMPLAINT 26 0.0010
488 MELAENA 22 0.0010
489 CIRCULATORY COLLAPSE 17 0.0010
490 OSTEOPOROSIS 41 0.0010
491 VISUAL ACUITY REDUCED 33 0.0010
492 RHINITIS 8 0.0010
493 SEASONAL ALLERGY 14 0.0010
494 SINUS TACHYCARDIA 14 0.0010
495 BLOOD POTASSIUM INCREASED 16 0.0010
496 DEEP VEIN THROMBOSIS 64 0.0010
497 ORAL PAIN 22 0.0010
498 BODY TEMPERATURE INCREASED 20 0.0010
499 OFF LABEL USE 858 0.0010
500 POLYURIA 8 0.0010
501 UROSEPSIS 9 0.0010
502 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
503 MENTAL STATUS CHANGES 27 0.0010
504 HYPERCALCAEMIA 12 0.0010
505 TREATMENT NONCOMPLIANCE 53 0.0010
506 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
507 HEPATIC ENCEPHALOPATHY 9 0.0010
508 DIPLOPIA 25 0.0010
509 FAECES SOFT 7 0.0010
510 CHRONIC KIDNEY DISEASE 73 0.0010
511 PRODUCT TASTE ABNORMAL 13 0.0010
512 MYOCARDITIS 11 0.0010
513 INTENTIONAL UNDERDOSE 7 0.0010
514 HAEMOGLOBIN DECREASED 98 0.0010
515 ACUTE HEPATIC FAILURE 13 0.0010
516 GOUT 17 0.0009
517 FULL BLOOD COUNT ABNORMAL 10 0.0009
518 TACHYCARDIA 84 0.0009
519 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
520 TASTE DISORDER 19 0.0009
521 OEDEMA PERIPHERAL 114 0.0009
522 DIARRHOEA 603 0.0009
523 HYPOMAGNESAEMIA 13 0.0009
524 VIRAL INFECTION 31 0.0009
525 BONE LOSS 14 0.0009
526 HAEMATOMA 24 0.0009
527 WOUND INFECTION 10 0.0009
528 MULTIPLE FRACTURES 15 0.0009
529 GASTROINTESTINAL PAIN 10 0.0009
530 CORONAVIRUS INFECTION 6 0.0009
531 VOMITING 426 0.0009
532 PANIC ATTACK 33 0.0009
533 APHASIA 27 0.0009
534 ANAL INCONTINENCE 8 0.0009
535 REBOUND EFFECT 10 0.0009
536 DEPRESSED LEVEL OF CONSCIOUSNESS 35 0.0009
537 SCAB 10 0.0009
538 ABORTION SPONTANEOUS 35 0.0009
539 HYPONATRAEMIA 49 0.0009
540 VENTRICULAR EXTRASYSTOLES 9 0.0009
541 DISEASE PROGRESSION 102 0.0009
542 HAEMOPTYSIS 24 0.0009
543 HEPATIC STEATOSIS 16 0.0009
544 TRANSFUSION 9 0.0009
545 BLOOD COUNT ABNORMAL 13 0.0009
546 HAEMATOCRIT DECREASED 17 0.0009
547 NEPHROPATHY 8 0.0009
548 FLANK PAIN 8 0.0009
549 SQUAMOUS CELL CARCINOMA 8 0.0008
550 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
551 BLOOD SODIUM DECREASED 16 0.0008
552 DIALYSIS 12 0.0008
553 PARALYSIS 12 0.0008
554 HERPES ZOSTER 48 0.0008
555 RASH 364 0.0008
556 HAEMODIALYSIS 7 0.0008
557 PARAESTHESIA ORAL 12 0.0008
558 ATRIAL FIBRILLATION 80 0.0008
559 NEUROPATHY PERIPHERAL 78 0.0008
560 BLISTER 46 0.0008
561 RENAL DISORDER 38 0.0008
562 DECREASED APPETITE 189 0.0008
563 RASH PRURITIC 44 0.0008
564 SENSORY DISTURBANCE 13 0.0008
565 HOSPICE CARE 8 0.0008
566 ARTHROPOD BITE 6 0.0008
567 GENERALISED OEDEMA 10 0.0008
568 HALLUCINATION, VISUAL 17 0.0008
569 THINKING ABNORMAL 15 0.0008
570 DEAFNESS 21 0.0008
571 HAEMORRHAGE INTRACRANIAL 12 0.0008
572 URINE OUTPUT DECREASED 7 0.0008
573 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
574 BRAIN OEDEMA 10 0.0008
575 MANIA 13 0.0008
576 MUSCLE ATROPHY 10 0.0008
577 HAEMATURIA 27 0.0008
578 INFECTION 114 0.0008
579 PHOTOSENSITIVITY REACTION 13 0.0008
580 DRUG DISPENSING ERROR 12 0.0008
581 EPISTAXIS 58 0.0008
582 SKIN ULCER 20 0.0008
583 OSTEOMYELITIS 14 0.0008
584 DELUSION 12 0.0008
585 COUGH 216 0.0008
586 THERAPY PARTIAL RESPONDER 12 0.0008
587 SUBDURAL HAEMATOMA 11 0.0008
588 TENDERNESS 8 0.0008
589 GASTROINTESTINAL INFLAMMATION 6 0.0008
590 PNEUMONIA ASPIRATION 19 0.0008
591 TOOTH INFECTION 10 0.0008
592 CHOLECYSTITIS 9 0.0008
593 ATRIAL FLUTTER 6 0.0008
594 PRESCRIBED UNDERDOSE 15 0.0008
595 LOCALISED INFECTION 18 0.0007
596 POOR QUALITY SLEEP 16 0.0007
597 FEEDING DISORDER 15 0.0007
598 PRODUCT USE IN UNAPPROVED INDICATION 183 0.0007
599 PANCREATITIS 39 0.0007
600 AMNESIA 48 0.0007
601 PULMONARY OEDEMA 33 0.0007
602 DECUBITUS ULCER 6 0.0007
603 ASPHYXIA 6 0.0007
604 DEHYDRATION 98 0.0007
605 LYMPHADENOPATHY 26 0.0007
606 RASH ERYTHEMATOUS 35 0.0007
607 ASPIRATION 8 0.0007
608 HYPERAESTHESIA 6 0.0007
609 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
610 NAUSEA 577 0.0007
611 PHARYNGITIS 9 0.0007
612 ACUTE CORONARY SYNDROME 6 0.0007
613 DIZZINESS POSTURAL 7 0.0007
614 SWELLING FACE 47 0.0007
615 DELIRIUM 25 0.0007
616 AUTOIMMUNE DISORDER 7 0.0007
617 ABDOMINAL PAIN 167 0.0007
618 DERMATITIS ALLERGIC 9 0.0007
619 INTESTINAL PERFORATION 8 0.0007
620 ABDOMINAL PAIN LOWER 18 0.0007
621 LABORATORY TEST ABNORMAL 21 0.0007
622 LACTIC ACIDOSIS 23 0.0007
623 STATUS EPILEPTICUS 8 0.0007
624 BLOOD PRESSURE FLUCTUATION 17 0.0007
625 INABILITY TO AFFORD MEDICATION 7 0.0007
626 BRAIN INJURY 7 0.0007
627 GENERAL PHYSICAL HEALTH DETERIORATION 80 0.0007
628 EYELID OEDEMA 8 0.0007
629 METABOLIC ACIDOSIS 22 0.0007
630 EPILEPSY 21 0.0007
631 RASH MACULAR 24 0.0007
632 CONTUSION 66 0.0007
633 DYSSTASIA 20 0.0007
634 INTENTIONAL PRODUCT USE ISSUE 60 0.0007
635 GASTRITIS 18 0.0007
636 PULMONARY CONGESTION 9 0.0007
637 OEDEMA 37 0.0007
638 ASTHENIA 256 0.0007
639 ACUTE MYOCARDIAL INFARCTION 20 0.0007
640 EYE DISCHARGE 7 0.0007
641 PRESCRIBED OVERDOSE 13 0.0007
642 RHABDOMYOLYSIS 28 0.0007
643 MYOCLONUS 8 0.0007
644 UVEITIS 9 0.0007
645 HYPOTENSION 133 0.0007
646 DYSPNOEA 375 0.0007
647 PRODUCT AVAILABILITY ISSUE 15 0.0007
648 PRESYNCOPE 16 0.0007
649 INSURANCE ISSUE 10 0.0007
650 ANXIETY 186 0.0007
651 RESPIRATORY TRACT INFECTION 17 0.0007
652 SPINAL FRACTURE 13 0.0006
653 INFUSION RELATED REACTION 43 0.0006
654 FAECES DISCOLOURED 14 0.0006
655 MIDDLE INSOMNIA 12 0.0006
656 PULMONARY THROMBOSIS 7 0.0006
657 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
658 RESPIRATORY DISORDER 19 0.0006
659 FEAR 17 0.0006
660 CONFUSIONAL STATE 102 0.0006
661 DISORIENTATION 25 0.0006
662 LOCAL SWELLING 11 0.0006
663 THROAT TIGHTNESS 17 0.0006
664 RESTLESSNESS 23 0.0006
665 PRODUCTIVE COUGH 30 0.0006
666 EMOTIONAL DISTRESS 76 0.0006
667 URTICARIA 105 0.0006
668 LETHARGY 36 0.0006
669 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
670 HOSPITALISATION 96 0.0006
671 MITRAL VALVE INCOMPETENCE 7 0.0006
672 FLUID OVERLOAD 9 0.0006
673 ABDOMINAL PAIN UPPER 127 0.0006
674 GALLBLADDER DISORDER 11 0.0006
675 FOETAL EXPOSURE DURING PREGNANCY 50 0.0006
676 CEREBRAL INFARCTION 15 0.0006
677 MYELOSUPPRESSION 22 0.0006
678 OSTEONECROSIS 20 0.0006
679 IMMUNE SYSTEM DISORDER 8 0.0006
680 DYSGEUSIA 45 0.0006
681 BLOOD PRESSURE ABNORMAL 12 0.0006
682 GASTROINTESTINAL DISORDER 54 0.0006
683 THERAPEUTIC RESPONSE UNEXPECTED 27 0.0006
684 DYSPHAGIA 57 0.0006
685 COAGULOPATHY 10 0.0006
686 MUSCULAR WEAKNESS 68 0.0006
687 GASTROINTESTINAL HAEMORRHAGE 50 0.0006
688 HEART RATE DECREASED 21 0.0006
689 CONSTIPATION 130 0.0006
690 MATERNAL EXPOSURE DURING PREGNANCY 53 0.0006
691 SINUS CONGESTION 8 0.0006
692 EYE SWELLING 22 0.0006
693 BLOOD IRON DECREASED 7 0.0006
694 PALPITATIONS 69 0.0006
695 NEPHROLITHIASIS 27 0.0006
696 GINGIVAL BLEEDING 8 0.0006
697 POLYNEUROPATHY 7 0.0006
698 INFLAMMATION 30 0.0006
699 FRACTURE 11 0.0006
700 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17 0.0006
701 FOOT FRACTURE 11 0.0006
702 RASH PAPULAR 13 0.0006
703 BLOOD URINE PRESENT 11 0.0006
704 EJECTION FRACTION DECREASED 9 0.0006
705 CRYING 21 0.0006
706 CHEST PAIN 107 0.0006
707 CONVULSION 33 0.0006
708 PULMONARY HYPERTENSION 12 0.0006
709 COORDINATION ABNORMAL 8 0.0006
710 APHONIA 8 0.0006
711 MASS 8 0.0006
712 FOLLICULITIS 6 0.0006
713 BLOOD TEST ABNORMAL 8 0.0006
714 PULMONARY EMBOLISM 54 0.0006
715 HALLUCINATION, AUDITORY 9 0.0006
716 BLOOD POTASSIUM DECREASED 17 0.0006
717 HEART RATE INCREASED 56 0.0006
718 ANGIOEDEMA 25 0.0006
719 ILEUS 7 0.0006
720 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
721 IMPAIRED WORK ABILITY 12 0.0006
722 AGGRESSION 28 0.0006
723 SECRETION DISCHARGE 7 0.0006
724 HYPERSOMNIA 16 0.0006
725 CARDIOGENIC SHOCK 8 0.0006
726 GASTROENTERITIS VIRAL 10 0.0006
727 VAGINAL HAEMORRHAGE 24 0.0006
728 PRODUCT PRESCRIBING ISSUE 12 0.0006
729 EXPOSURE DURING PREGNANCY 34 0.0005
730 BONE PAIN 32 0.0005
731 FATIGUE 425 0.0005
732 ANAPHYLACTIC SHOCK 14 0.0005
733 HYPERTENSION 115 0.0005
734 RHINORRHOEA 35 0.0005
735 VERTIGO 33 0.0005
736 UPPER RESPIRATORY TRACT INFECTION 25 0.0005
737 WEIGHT DECREASED 151 0.0005
738 INSOMNIA 144 0.0005
739 SKIN DISORDER 18 0.0005
740 WHEEZING 32 0.0005
741 DIZZINESS 269 0.0005
742 DRUG INTOLERANCE 52 0.0005
743 INFLUENZA 60 0.0005
744 PLATELET COUNT INCREASED 7 0.0005
745 BLOOD PRESSURE INCREASED 82 0.0005
746 MALAISE 235 0.0005
747 RIB FRACTURE 11 0.0005
748 NEURALGIA 13 0.0005
749 PHOTOPHOBIA 10 0.0005
750 EYE INFECTION 6 0.0005
751 FLUID RETENTION 27 0.0005
752 HYPOAESTHESIA ORAL 8 0.0005
753 EAR INFECTION 14 0.0005
754 SKIN DISCOLOURATION 24 0.0005
755 HEADACHE 327 0.0005
756 OROPHARYNGEAL PAIN 48 0.0005
757 ERUCTATION 10 0.0005
758 IMPAIRED GASTRIC EMPTYING 7 0.0005
759 ORAL HERPES 10 0.0005
760 SWOLLEN TONGUE 16 0.0005
761 RECTAL HAEMORRHAGE 22 0.0005
762 COLD SWEAT 9 0.0005
763 ILL-DEFINED DISORDER 31 0.0005
764 URINARY TRACT INFECTION 87 0.0005
765 VISION BLURRED 70 0.0005
766 PRURITUS GENERALISED 11 0.0005
767 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
768 ABDOMINAL DISCOMFORT 85 0.0005
769 DIVERTICULITIS 14 0.0005
770 DYSARTHRIA 19 0.0005
771 RESPIRATORY TRACT CONGESTION 8 0.0005
772 FEELING COLD 14 0.0005
773 PREMATURE DELIVERY 8 0.0005
774 ABSCESS 8 0.0005
775 INFLUENZA LIKE ILLNESS 41 0.0005
776 CHEST DISCOMFORT 51 0.0005
777 GASTRIC DISORDER 17 0.0005
778 BONE DISORDER 9 0.0005
779 HYPERSENSITIVITY 91 0.0005
780 SYNCOPE 49 0.0005
781 ABDOMINAL DISTENSION 51 0.0005
782 TREMOR 81 0.0005
783 CARDIOMEGALY 6 0.0005
784 BRONCHITIS 36 0.0005
785 CARDIAC FAILURE 39 0.0005
786 ARRHYTHMIA 23 0.0005
787 ABASIA 12 0.0005
788 DISTURBANCE IN ATTENTION 26 0.0005
789 APATHY 7 0.0005
790 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
791 TINNITUS 22 0.0005
792 CARDIO-RESPIRATORY ARREST 20 0.0005
793 MUSCLE TWITCHING 11 0.0005
794 CARDIOMYOPATHY 7 0.0005
795 CARDIAC ARREST 39 0.0005
796 GASTROOESOPHAGEAL REFLUX DISEASE 38 0.0005
797 EATING DISORDER 10 0.0005
798 LOWER LIMB FRACTURE 9 0.0005
799 THERAPY NON-RESPONDER 21 0.0005
800 LUNG NEOPLASM MALIGNANT 19 0.0005
801 PRODUCT PRESCRIBING ERROR 11 0.0005
802 DYSPHONIA 27 0.0005
803 HAEMORRHOIDS 9 0.0005
804 DRY EYE 23 0.0005
805 BACK PAIN 107 0.0005
806 MENTAL DISORDER 20 0.0005
807 ORTHOSTATIC HYPOTENSION 8 0.0005
808 MENTAL IMPAIRMENT 11 0.0005
809 HAEMATOCHEZIA 25 0.0005
810 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
811 LUNG INFECTION 7 0.0005
812 NERVOUS SYSTEM DISORDER 14 0.0004
813 MYALGIA 76 0.0004
814 GLOSSODYNIA 10 0.0004
815 BRAIN FOG 7 0.0004
816 SEIZURE 51 0.0004
817 PRURITUS 169 0.0004
818 ECZEMA 23 0.0004
819 URINARY INCONTINENCE 13 0.0004
820 SWELLING 41 0.0004
821 ACCIDENTAL OVERDOSE 16 0.0004
822 LOSS OF CONSCIOUSNESS 56 0.0004
823 HAEMATEMESIS 11 0.0004
824 HYPOGLYCAEMIA 21 0.0004
825 DERMATITIS 9 0.0004
826 THERAPY CESSATION 22 0.0004
827 FEELING HOT 26 0.0004
828 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
829 TOXICITY TO VARIOUS AGENTS 71 0.0004
830 LIP SWELLING 14 0.0004
831 SPEECH DISORDER 22 0.0004
832 URINARY RETENTION 14 0.0004
833 DRY MOUTH 34 0.0004
834 BLINDNESS 17 0.0004
835 PERICARDITIS 7 0.0004
836 DRUG INEFFECTIVE 548 0.0004
837 HYPERTHYROIDISM 6 0.0004
838 SCAR 7 0.0004
839 DEPRESSION 93 0.0004
840 ILLNESS 42 0.0004
841 KIDNEY INFECTION 8 0.0004
842 DYSURIA 15 0.0004
843 LIMB INJURY 11 0.0004
844 TOOTH DISORDER 9 0.0004
845 DISABILITY 8 0.0004
846 ABNORMAL BEHAVIOUR 16 0.0004
847 HYPERHIDROSIS 52 0.0004
848 SKIN EXFOLIATION 34 0.0004
849 OCULAR HYPERAEMIA 19 0.0004
850 MUSCLE SPASMS 73 0.0004
851 SLEEP DISORDER 28 0.0004
852 PERIPHERAL SWELLING 61 0.0004
853 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
854 PARAESTHESIA 62 0.0004
855 DIABETES MELLITUS 30 0.0004
856 NASAL CONGESTION 23 0.0004
857 PAIN 238 0.0004
858 TOOTH LOSS 8 0.0004
859 BURNING SENSATION 27 0.0004
860 CYANOSIS 6 0.0004
861 JOINT STIFFNESS 10 0.0004
862 DEATH 328 0.0004
863 BLOOD GLUCOSE ABNORMAL 7 0.0004
864 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
865 SKIN CANCER 8 0.0004
866 BALANCE DISORDER 32 0.0004
867 CATARACT 22 0.0004
868 GASTRIC ULCER 7 0.0004
869 MUSCULOSKELETAL DISORDER 7 0.0004
870 PALLOR 10 0.0004
871 FEELING JITTERY 7 0.0004
872 POST PROCEDURAL COMPLICATION 7 0.0004
873 PRODUCT USE ISSUE 68 0.0004
874 BLOOD PRESSURE DECREASED 24 0.0004
875 PRODUCT DOSE OMISSION ISSUE 106 0.0004
876 EAR PAIN 7 0.0004
877 NEOPLASM MALIGNANT 24 0.0004
878 DRUG ADMINISTRATION ERROR 11 0.0004
879 ADVERSE EVENT 33 0.0004
880 UNEVALUABLE EVENT 27 0.0004
881 THROAT IRRITATION 16 0.0004
882 TYPE 2 DIABETES MELLITUS 12 0.0004
883 ADVERSE DRUG REACTION 32 0.0004
884 DYSPEPSIA 35 0.0004
885 UPPER LIMB FRACTURE 7 0.0004
886 CYSTITIS 11 0.0003
887 ERYTHEMA 71 0.0003
888 NERVOUSNESS 18 0.0003
889 ANAPHYLACTIC REACTION 19 0.0003
890 SINUSITIS 35 0.0003
891 DEPRESSED MOOD 18 0.0003
892 AGITATION 25 0.0003
893 NECK PAIN 19 0.0003
894 EYE PAIN 19 0.0003
895 POLLAKIURIA 14 0.0003
896 COLITIS ULCERATIVE 15 0.0003
897 CEREBRAL HAEMORRHAGE 12 0.0003
898 FLATULENCE 19 0.0003
899 HYPOAESTHESIA 50 0.0003
900 EYE PRURITUS 11 0.0003
901 OSTEONECROSIS OF JAW 8 0.0003
902 JOINT SWELLING 39 0.0003
903 AGEUSIA 8 0.0003
904 BRADYCARDIA 17 0.0003
905 GAIT DISTURBANCE 61 0.0003
906 SOMNOLENCE 64 0.0003
907 PAIN IN JAW 9 0.0003
908 COMA 15 0.0003
909 NASOPHARYNGITIS 58 0.0003
910 MOVEMENT DISORDER 10 0.0003
911 CARDIAC FAILURE CONGESTIVE 25 0.0003
912 THROMBOSIS 25 0.0003
913 UNRESPONSIVE TO STIMULI 8 0.0003
914 IRRITABILITY 18 0.0003
915 VISUAL IMPAIRMENT 37 0.0003
916 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
917 ARTHRALGIA 123 0.0003
918 ALOPECIA 58 0.0003
919 SUICIDAL IDEATION 27 0.0003
920 THERAPY INTERRUPTED 21 0.0003
921 PAIN IN EXTREMITY 85 0.0003
922 WOUND 8 0.0003
923 WEIGHT INCREASED 64 0.0003
924 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
925 OSTEOARTHRITIS 12 0.0003
926 MOOD SWINGS 9 0.0003
927 HYPOTHYROIDISM 9 0.0003
928 THERAPEUTIC RESPONSE DECREASED 17 0.0003
929 FALL 93 0.0003
930 COGNITIVE DISORDER 13 0.0003
931 DYSKINESIA 11 0.0003
932 INJURY 19 0.0003
933 MEDICATION ERROR 15 0.0003
934 DRY SKIN 36 0.0003
935 RENAL INJURY 8 0.0003
936 MEMORY IMPAIRMENT 37 0.0003
937 HEART RATE IRREGULAR 6 0.0003
938 FEELING ABNORMAL 63 0.0003
939 DISCOMFORT 16 0.0003
940 BLOOD CHOLESTEROL INCREASED 12 0.0003
941 PROCEDURAL PAIN 7 0.0003
942 ARTHROPATHY 14 0.0003
943 HIP FRACTURE 8 0.0002
944 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
945 ANGINA PECTORIS 7 0.0002
946 ROAD TRAFFIC ACCIDENT 10 0.0002
947 INTESTINAL OBSTRUCTION 9 0.0002
948 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 43 0.0002
949 PREMATURE BABY 7 0.0002
950 HAEMORRHAGE 24 0.0002
951 ARTHRITIS 18 0.0002
952 FEMUR FRACTURE 7 0.0002
953 ACNE 17 0.0002
954 FREQUENT BOWEL MOVEMENTS 6 0.0002
955 CEREBROVASCULAR ACCIDENT 37 0.0002
956 PRODUCT DOSE OMISSION 14 0.0002
957 PRODUCT QUALITY ISSUE 29 0.0002
958 EYE DISORDER 7 0.0002
959 HOT FLUSH 16 0.0002
960 UNDERDOSE 15 0.0002
961 SUICIDE ATTEMPT 12 0.0002
962 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
963 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
964 OVERDOSE 42 0.0002
965 EMOTIONAL DISORDER 6 0.0002
966 MUSCULOSKELETAL PAIN 10 0.0002
967 ASTHMA 21 0.0002
968 MIGRAINE 17 0.0002
969 ANGER 6 0.0002
970 DRUG DOSE OMISSION 29 0.0002
971 INTENTIONAL OVERDOSE 11 0.0002
972 INTENTIONAL PRODUCT MISUSE 15 0.0002
973 MUSCULOSKELETAL STIFFNESS 15 0.0002
974 CARDIAC DISORDER 16 0.0002
975 SURGERY 10 0.0002
976 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
977 EYE IRRITATION 9 0.0002
978 PRODUCT SUBSTITUTION ISSUE 9 0.0002
979 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
980 BLOOD GLUCOSE INCREASED 29 0.0002
981 MOBILITY DECREASED 11 0.0002
982 MYOCARDIAL INFARCTION 26 0.0001
983 PSORIASIS 18 0.0001
984 INCORRECT DOSE ADMINISTERED 31 0.0001
985 FLUSHING 12 0.0001
986 PRODUCT STORAGE ERROR 10 0.0001
987 DERMATITIS ATOPIC 6 0.0001
988 NO ADVERSE EVENT 20 0.0001
989 INJECTION SITE HAEMORRHAGE 7 0.0001
990 COMPLETED SUICIDE 7 0.0001
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
992 INJECTION SITE ERYTHEMA 8 0.0001
993 RHEUMATOID ARTHRITIS 7 0.0001
994 INJECTION SITE PAIN 18 0.0001